Cargando…

A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae

Background Multisystem involvement in coronavirus disease 2019 (COVID-19) is known since the beginning of the pandemic, and post-COVID-19 sequelae have often been reported. The term 'long Covid' encompasses these signs and symptoms. The aim of our study was to study different after-effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Gujral, Harshmeet Singh, Sahasrabudhe, Tushar R, Nirmala, M A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359831/
https://www.ncbi.nlm.nih.gov/pubmed/37485095
http://dx.doi.org/10.7759/cureus.40717
_version_ 1785075970143682560
author Gujral, Harshmeet Singh
Sahasrabudhe, Tushar R
Nirmala, M A
author_facet Gujral, Harshmeet Singh
Sahasrabudhe, Tushar R
Nirmala, M A
author_sort Gujral, Harshmeet Singh
collection PubMed
description Background Multisystem involvement in coronavirus disease 2019 (COVID-19) is known since the beginning of the pandemic, and post-COVID-19 sequelae have often been reported. The term 'long Covid' encompasses these signs and symptoms. The aim of our study was to study different after-effects which patients endured within 12 months after recovery from acute COVID-19 and to study the various risk predictors. Methods This was a longitudinal observational study of a cohort of 146 patients who recovered from COVID-19 illness. Patients were enrolled during the first four weeks of the onset of their illness, and a monthly follow-up assessment was done for six months that included a detailed history of persistent or new symptoms, new illnesses diagnosed, and complete biochemical, pulmonary, cardiac, neurological and psychiatric evaluation, both objective and subjective. A final follow-up was also done at the end of one year of enrolment. Based on the patient’s self-reported history and our multi-system assessment, recorded sequelae were classified according to the involved organ system. These were correlated with possible risk predictors and statistically significant associations were established. Results One hundred and twenty subjects out of 146 total subjects qualified for final analysis. Pulmonary sequelae (48/120; 40%) were the most followed by psychiatric (30/120; 25%), neurological (26/120; 21.7%), and opportunistic infections (7/120; 5.8%). A total of 39/120 (32.1%) cases complained of prolonged dyspnoea. Six out of 120 i.e. 5% of study participants had new-onset diabetes. Twenty-six out of 120 (21.7%) had radiological signs of pulmonary fibrosis. Patients with co-morbidities, older age, higher body mass index, and patients with severe disease were found to be at higher risk of developing these sequelae. Poor nutrition, female gender, and hospitalization were predictors of psychiatric sequelae. Diabetes and liberal steroid use during COVID-19 management were predictors of opportunistic fungal infections. Conclusion This study evaluated post-COVID-19 sequalae in-depth both objectively and subjectively. Some specific predictors for specific sequelae were confirmed on statistical correlation. Long-term follow-up of high-risk persons is therefore recommended after the cure of COVID-19.
format Online
Article
Text
id pubmed-10359831
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103598312023-07-22 A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae Gujral, Harshmeet Singh Sahasrabudhe, Tushar R Nirmala, M A Cureus Internal Medicine Background Multisystem involvement in coronavirus disease 2019 (COVID-19) is known since the beginning of the pandemic, and post-COVID-19 sequelae have often been reported. The term 'long Covid' encompasses these signs and symptoms. The aim of our study was to study different after-effects which patients endured within 12 months after recovery from acute COVID-19 and to study the various risk predictors. Methods This was a longitudinal observational study of a cohort of 146 patients who recovered from COVID-19 illness. Patients were enrolled during the first four weeks of the onset of their illness, and a monthly follow-up assessment was done for six months that included a detailed history of persistent or new symptoms, new illnesses diagnosed, and complete biochemical, pulmonary, cardiac, neurological and psychiatric evaluation, both objective and subjective. A final follow-up was also done at the end of one year of enrolment. Based on the patient’s self-reported history and our multi-system assessment, recorded sequelae were classified according to the involved organ system. These were correlated with possible risk predictors and statistically significant associations were established. Results One hundred and twenty subjects out of 146 total subjects qualified for final analysis. Pulmonary sequelae (48/120; 40%) were the most followed by psychiatric (30/120; 25%), neurological (26/120; 21.7%), and opportunistic infections (7/120; 5.8%). A total of 39/120 (32.1%) cases complained of prolonged dyspnoea. Six out of 120 i.e. 5% of study participants had new-onset diabetes. Twenty-six out of 120 (21.7%) had radiological signs of pulmonary fibrosis. Patients with co-morbidities, older age, higher body mass index, and patients with severe disease were found to be at higher risk of developing these sequelae. Poor nutrition, female gender, and hospitalization were predictors of psychiatric sequelae. Diabetes and liberal steroid use during COVID-19 management were predictors of opportunistic fungal infections. Conclusion This study evaluated post-COVID-19 sequalae in-depth both objectively and subjectively. Some specific predictors for specific sequelae were confirmed on statistical correlation. Long-term follow-up of high-risk persons is therefore recommended after the cure of COVID-19. Cureus 2023-06-21 /pmc/articles/PMC10359831/ /pubmed/37485095 http://dx.doi.org/10.7759/cureus.40717 Text en Copyright © 2023, Gujral et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Gujral, Harshmeet Singh
Sahasrabudhe, Tushar R
Nirmala, M A
A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae
title A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae
title_full A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae
title_fullStr A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae
title_full_unstemmed A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae
title_short A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae
title_sort systematic evaluation of risk predictors for covid-19 sequelae
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359831/
https://www.ncbi.nlm.nih.gov/pubmed/37485095
http://dx.doi.org/10.7759/cureus.40717
work_keys_str_mv AT gujralharshmeetsingh asystematicevaluationofriskpredictorsforcovid19sequelae
AT sahasrabudhetusharr asystematicevaluationofriskpredictorsforcovid19sequelae
AT nirmalama asystematicevaluationofriskpredictorsforcovid19sequelae
AT gujralharshmeetsingh systematicevaluationofriskpredictorsforcovid19sequelae
AT sahasrabudhetusharr systematicevaluationofriskpredictorsforcovid19sequelae
AT nirmalama systematicevaluationofriskpredictorsforcovid19sequelae